• English
    • español
    • português (Brasil)
  • English 
    • English
    • español
    • português (Brasil)
  • Login
View Item 
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • View Item
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

COVID-19: Roche Antibody Test – 14th May

 
Thumbnail
Date
2020-05-14
Author
Fleming, Susannah
Heneghan, Carl
Metadata
Show full item record
Abstract
What do sensitivity and specificity tell us? Sensitivity tells us the proportion of people who test positive, out of the population who should have tested positive. In this case, a sensitivity of 100% tells us that everybody with a history of COVID-19 infection had a positive antibody test. (Tests with sensitivity or specificity that are truly 100% are very rare. I suspect that in this case, the sensitivity is very high, but maybe not actually 100%.) Specificity tells us the proportion of people who test negative, out of the population who should have tested negative. In this case, a specificity of 99.8% tells us that 2 in 1000 people (0.2%) tested positive with the antibody test, even though they should have tested negative. Surely this is all fine? 99.8% and 100% are both big numbers. But what does it mean for an individual who receives an antibody test result? Well, sensitivity and specificity can’t really help us. They tell us about what happens if we already know what the right answer should have been. But if you’re having a test, the whole point is that you don’t know the right answer. You get a test result, and you want to know how likely it is to be correct.
URI
https://www.cebm.net/covid-19/covid-19-roche-antibody-test-14th-may/
Collections
  • Technical documents and research evidence on COVID-19

Browse

AllCommunities & CollectionsBy Issue DateAuthorsTitlesCategorySubjectsThis CollectionBy Issue DateAuthorsTitlesCategorySubjects

My Account

LoginRegister

Pan American Health Organization
World Health Organization. Regional Office for the Americas
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America

Content Disclaimer (Important notes about the material)

Links

  • WHO International Clinical Trial Registry Platform (ICTRP)
  • WHO Coronavirus disease R&D Blueprint
  • WHO Database of Publications on Coronavirus Disease
  • PAHO Coronavirus Disease
  • PAHO/BIREME Windows of Knowledge COVID-19
  • Evidence aid Coronavirus (COVID-19) resources

  • PAHO Digital Library (IRIS PAHO)
  • Virtual Health Library (VHL)
  • Global Index Medicus (GIM)